BioWorld MedTech

Aug. 20, 2014

Financings: HQC closes debut fund at $110M to invest in healthcare sectors

HealthQuest Capital (HQC; Menlo Park, California), a new fund sponsored by Sofinnova Ventures, reported the closing of its debut fund at the hard cap of $110 million and in excess of the initial fund target of $50 million. Read More

Nasal brush test could safely diagnose early prion infection in patients

Medtronic sees profit decline, improvement in sales for 1Q14

Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities

HIT Bits: Firm shows how crucial EMRs are in the big data revolution

Agreements/contracts: Cytori and BARDA continue cell development for thermal burns

Daily M&A: LeMaitre Vascular acquires Xenotis for $7.7 million

Product briefs

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...